NIH STTR Phase II (Omnibus)
Funds United States small-business and research-partner teams advancing biomedical projects already proven in early studies.
The NIH STTR Phase II Omnibus funds the full R&D execution phase of a technology that has cleared STTR Phase I feasibility review, issued under activity code R42 with the same $2,045,816 total-cost cap and one-to-three-year performance period as its SBIR Phase II counterpart. NIH disburses approximately $65 million per fiscal year in STTR Phase II awards. The program continues the formal collabora…
Continuation of a successful STTR Phase I project, with continued formal collaboration between the small business and the non-profit research-institution partner.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up